EZH2 and breast cancer: In line with this, a further study showed that EZH2 was upregulated in cisplatin-resistant breast cancer tissue (tumor tissue from 48 breast cancer patients) and cell lines (MCF-7/CDDP and MDA-MB231/CDDP compared with parental cells).